Status:

COMPLETED

Brain Imaging of Tinnitus

Lead Sponsor:

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Hearing Disorder

Eligibility:

All Genders

30-65 years

Brief Summary

This study will use magnetic resonance imaging (MRI) to compare brain function in three groups of people: hearing-impaired people with tinnitus; hearing-impaired people without tinnitus; and people wi...

Detailed Description

Subjective tinnitus, the false perception of sound in the absence of an acoustic stimulus, occurs frequently as a consequence of noise-induced deafness. The purpose of this study is to investigate the...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Plus Tinnitus Plus Hearing loss subjects.
  • Adults, between the ages of 30 to 65 years.
  • Are able to hear and perceive sounds used in the experiment in the range 250 Hz to 2 KHz and have high-frequency sensorineural hearing loss beginning no lower than 2 KHz.
  • In good health and not currently taking certain medications regularly (e.g. antidepressants, antiseizure medications, antipsychotics, etc.).
  • Experience tinnitus daily.
  • Have had non-pulsatile tinnitus for at least 1 year.
  • Have bilateral or bilateral with unilateral dominance tinnitus.
  • Minus Tinnitus Plus Hearing loss subjects.
  • Adults, between the ages of 30 to 65 years.
  • Are able to hear and perceive sounds used in the experiment in the range 250 Hz to 2 KHz and have high-frequency sensorineural hearing loss beginning no lower than 2 KHz.
  • In good health and not currently taking certain medications regularly (e.g. antidepressants, antiseizure medications, antipsychotics, etc.).
  • Have never or rarely (i.e. transient episodes experienced by virtually everyone) experienced tinnitus.
  • Minus Tinnitus Minus Hearing loss subjects or normal volunteers.
  • Adults, between the ages of 30 to 65 years.
  • Have normal hearing.
  • In good health and not currently taking certain medications regularly (e.g. antidepressants, antiseizure medications, antipsychotics, etc.).
  • EXCLUSION CRITERIA:
  • Subjects who have pacemakers, aneurysm clips, metallic prostheses or shrapnel fragments.
  • Subjects incapable of giving informed consent.
  • Subjects with a positive pregnancy test.
  • Children below the age of 18 years.
  • Subjects with hyperacusis or misophonia (hyper-sensitivity to loud noises).
  • Subjects with mood disturbances such as depression or anxiety.
  • Subjects with a history of temporomandibular joint problems or who present symptoms of pain and tenderness of the temporomandibular joint on examination.
  • Subjects may be excluded for the following reasons that may cause difficulty with interpretation of the imaging data:
  • Subjects with mental or physical illnesses, other than tinnitus that may cause problems with participation in the study.
  • Subjects with current uncontrolled hypertension, or significant past history of cardiovascular disease and diabetes melitus.
  • Subjects with a history of head trauma with loss of consciousness, epilepsy, seizures, a history of chemotherapy (neurotoxic or ototoxic) and other medical conditions that may alter cerebral functioning.
  • Subjects who are taking or have a history of taking recreational drugs or alcoholism.
  • Subjects with unilateral or asymmetrical hearing loss who have not had (or cannot provide documentation of) comprehensive neuro-otologic workup will be excluded.

Exclusion

    Key Trial Info

    Start Date :

    July 28 2006

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 7 2016

    Estimated Enrollment :

    58 Patients enrolled

    Trial Details

    Trial ID

    NCT00359931

    Start Date

    July 28 2006

    End Date

    March 7 2016

    Last Update

    October 6 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892